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Introduction
Parry–Romberg syndrome is an uncommon acquired slowly pro-
gressive hemifacial atrophy of unknown etiology that also rarely 
involves the ipsilateral part of the limbs (1). This syndrome has 
many features of linear scleroderma “en coup de sabre,” but it is 
characterized by more extensive involvement of the lower face 
with only a slight cutaneous sclerosis (2). It is due to gradual wast-
ing of the subcutaneous fat, accompanied by an atrophy of the 
skin and, infrequently, of the muscles and bones. In particular, 
bone and cartilage tissues are rarely affected, unless the onset oc-
curs before the second decade, when the face and skull structures 
are not fully developed (2). The average onset of this disease is 
in the first two decades, beginning with a progressive phase that 
may span up to 20 years and thereafter tending toward stabiliza-
tion (1). In 15% of the cases, neurological signs and symptoms 
such as trigeminal neuralgia, facial paresthesia, headache, and 
focal epilepsy are present (1). The pathogenesis of this syndrome 
remains unexplained: it is thought to be a unilateral inflamma-
tory process associated with a chronic vascular or neurogenic dis-
turbance such as sympathetic dysfunction (3). Other postulated 
causes include autoimmunity, inheritance, local trauma, focal 
scleroderma, endocrine and metabolic disorders, and other fac-
tors, including Borrelia burgdorferi sensu lato infections (1–4). 
The role of Borrelia burgdorferi sensu lato in the development of 
atrophosclerodermic diseases is well known even when the fa-
cial area is involved (5–7). In the literature there are few reports 
showing the association between Parry–Romberg syndrome and 
borreliosis (2, 8–11). We present another case of Parry–Romberg 
syndrome in which the correlation with Borrelia burgdorferi infec-
tion could be strongly suspected.
Case report
A 16-year-old woman from Albania presented with linear depres-
sions of the right side of the face, clinically compatible with Par-
ry–Romberg syndrome. She developed a progressive facial right 
asymmetry from the age of 11 and had no memory of any signifi-
cant local trauma and no family history of progressive hemifacial 
atrophy or similar conditions. Dermatological examination re-
vealed a linear atrophic depression of soft tissues, especially of 
the lower part of the right cheek and of the right side of the chin 
with labial asymmetry and tongue hemiatrophy. No eyebrow or 
forehead alopecia was present (Fig 1). There was no evidence of 
sensory or motor functional deficits on either side. Lyme ELISA 
(NovaTec Immunodiagnostica GmbH) IgM antibodies (antigens: 
Flagellin recombinant and purified OspC) were elevated in serum 
(178 UA/ml, normal values < 24 UA/ml), whereas IgG were nor-
mal. The IgM positivity was confirmed by immunoblot test (No-
vaTec Immunodiagnostica GmbH): 24 kDA(OspC), 41 kDA(Fla), 
39 kDA(p39). The patient remembered a tick bite 5 to 6 years ear-
lier in the upper right area of the neck, close to the subsequent 
atrophic area, with a history of a retarded surrounding erythema, 
spontaneously resolved, most likely attributable to an erythema 
chronicum migrans. At that time she was not tested. A complete 
blood cell count, chemistry panel, and lipid profile revealed un-
remarkable findings. Serum and urine protein electrophoresis 
tests produced normal results, as did liver-, renal-, and thyroid-
function tests, erythrocyte sedimentation rate, C-reactive protein 
level, antinuclear antibodies, human immunodeficiency virus an-
tibodies, hepatitis B and C surface antigens, and VDRL test. Only 
a low count of CD57+ natural killer cells was present. Polymerase 
chain reaction real time (RT-PCR) assay for Borrelia burgdorferi 
sensu lato detection, performed on DNA obtained from peripheral 
blood, was positive. The patient refused a new biopsy on her face 
in order to perform a culture of Borrelia burgorferi sensu lato. All 
subcutaneous structures were intact: an X-ray of the facial mass 
showed that the two halves of the facial skeleton were symmetri-
cal and regularly developed. No consistent central and peripheral 
nervous system disorder was noticed, neither based on patient
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history or physical and electrographic examination (EEG), nor 
based on the quality of cerebrospinal fluid (colorless, with a nega-
tive Pandy reaction and with glucose, electrolytes, and proteins 
in the normal range) and on neuroimaging (brain and brainstem 
SPECT and MRI). In line with serological positivity for Lyme dis-
ease, the patient underwent an intravenous antibiotic treatment 
with intravenous penicillin G at a dosage of 20 million units per 
day associated with intravenous metronidazole (500 mg daily) for 
14 days. After 6 months, the IgM antibodies were 89 UA/ml, with 
the same immunoblot panel and blood PCR negative. After 14 
months, the IgM antibodies were 36 UA/ml, the IgM immunoblot 
was positive for p39 and p41, and blood PCR was negative. After 
24 months, the clinical disease progression had definitely halted 
and IgM antibodies as well as blood PCR for Borrelia burgdorferi 
sensu lato were negative. In order to correct the residual facial 
asymmetry and reshape the facial contour, a lipostructure session 
was carried out (Fig. 2).
Discussion
Since the first description of Parry–Romberg syndrome in 1825, 
this syndrome has aroused questions and reflection about its 
pathogenesis. It is not yet well known and seems to be hetero-
geneous, including trauma, infection, heredity, vascular malfor-
mation, auto-immunity, endocrine disturbances, disturbance of 
fat metabolism, and sympathetic dysfunction (12). Although the 
relationship of Borrelia burgdorferi sensu lato infection to Par-
ry–Romberg syndrome has occasionally been reported, the role 
of Borrelia burgdorferi sensu lato in the development of Parry–
Romberg syndrome is uncertain (2, 8–14). In a retrospective study 
on 12 patients with progressive facial atrophy, Sommer et al. (14) 
reported no association of both disorders. In contrast, our case 
indicates that there is strong evidence that Borrelia burgdorferi 
sensu lato infection is related to Parry–Romberg syndrome. Pro-
gressive facial hemiatrophy began when the woman was only 11 
years old. She recalled a previous history of an annular lesion, 
likely an erythema chronicum migrans, that appeared after a tick 
bite. No information is available on whether antibiotic treatment 
was offered. Her serology for Lyme disease was positive, although 
only for IgM. OspC and p39 are proteins highly specific for Bor-
relia burgdorferi sensu lato. P41 is specific for the various Borrelia 
species of the same genus. Borrelia burgdorferi sensu lato–spe-
cific gene segments by real-time blood PCR were detected (using 
a locally developed method that amplifies a fragment of flagel-
lin gene). The decrease in the CD57 lymphocyte subset may be a 
marker of Lyme disease (15). After the antibiotic therapy, we no-
ticed an interruption of progression of the disease. 
All these data indicate a probable Borrelia burgdorferi sensu 
lato infection. One could argue that the presence of IgM is sig-
nificant for an early infection, but it is well known that both IgM 
and IgG Borrelia–specific antibodies may persist for years in some 
patients, which makes it impossible to distinguish between past 
and newly acquired infections based on seropositivity alone (16). 
Antibodies against Borrelia burgdorferi sensu lato in the IgM class 
Figure 1 | Clinical aspect of Perry-Romberg syndrome before treatment.
Figure 2 | Clinical aspect of Perry–Romberg Syndrome after antibiotic treatment and lipostructure.
79
Acta Dermatovenerol APA | 2015;24:77-79 Parry–Romberg in Lyme disease
were found in another report in one of two patients with Parry–
Romberg syndrome (13). There are many factors (known and un-
known) that affect IgM positivity and can interfere with the test 
and consequently the test results. A prolonged and isolated IgM 
response is often detected, even years later in a subset of patients. 
This may certainly be due to a false-positive test. On the other 
hand, continual IgM production with no isotype switching to IgG 
was postulated in patients with active disease. In our patient, we 
noticed a progressive decrease in the IgM titer during follow-up 
after antibiotic therapy.
It is also possible that two separate disease states coexisted co-
incidentally in this patient, with no cause-and-effect relationship. 
Some authors support this hypothesis (13, 14), but it is remark-
able that several reports from different parts of the world show 
cases of Parry–Romberg syndrome associated with Lyme disease. 
We cannot exclude a coincidence; however, the bacteriological 
and serological evidence and furthermore the interruption of the 
disease progression after the antibiotic therapy are difficult to ig-
nore without claiming that this association is at least suggestive. 
All other cases not correlated with Lyme disease still remain to be 
References
1. Madasamy R, Jayanandan M, Revathy Adhavan U, Gopalakrishnan S, Mahen-
dra L. Parry Romberg syndrome: A case report and discussion. J Oral Maxillofac 
Pathol. 2012;16:406-10.
2. Sahin MT, Bariş S, Karaman A. Parry–Romberg syndrome: a possible associa-
tion with borreliosis. J Eur Acad Dermatol Venereol. 2004;18:204-7.
3. Kaliyadan F, Biswas K, Dharmaratnam AD. Progressive facial hemiatrophy—a 
case series. Indian J Dermatol. 2011;56:557-60
4. Verma R, Ram H, Gupta M, Vidhate MR. A case of extensive left-sided facial atro-
phy of Romberg. Natl J Maxillofac Surg. 2013;4:77-80.
5. Trevisan G, Rees DH, Stinco G. Borrelia burgdorferi and localized scleroderma. 
Clin Dermatol. 1994;12:475-9.
6. Gubertini N, Bonin S, Trevisan G. Lichen sclerosus et atrophicans, scleroderma 
en coup de sabre and Lyme borreliosis. Dermatol Reports. 2011;3:e27. doi: 
10.4081/dr.2011.e27.
7. Stinco G, Trevisan G, Martina Patriarca M, Ruscio M, Di Meo N, Patrone P. Acro-
dermatitis chronica atrophicans of the face: a case report and a brief review of 
the literature. Acta Dermatovenereol Croat. 2014;22:205-8.
8. Abele DC, Bedingfield RB, Chandler FW, Given KS. Progressive facial hemia-
trophy (Parry–Romberg syndrome) and borreliosis. J Am Acad Dermatol. 
1990;22:531-3.
9. Stern HS, Elliott LF, Beegle PH Jr. Progressive hemifacial atrophy associated with 
Lyme disease. Plast Reconstr Surg. 1992;90:479-83.
10. Salpietro DC, Merlino MV, Bruglia S, Guarneri F, Vaccaro M. Linear scleroderma 
“en coup de sabre” associated with facial atrophy in a patient seropositive for 
Borrelia burgdorferi: a true case of molecular mimicry? Pediatr Allergy Immunol. 
2004;15:570-2.
11. Baskan EB, Kaçar SD, Turan A, Saricaoglu H, Tunali S, Adim SB. Parry–Romb-
erg syndrome associated with borreliosis: could photochemotherapy halt the 
progression of the disease? Photodermatol Photoimmunol Photomed. 2006;22: 
259-61.
12. El-Kehdy J, Abbas O, Rubeiz N. A review of Parry–Romberg syndrome. J Am Acad 
Dermatol. 2012;67:769-84.
13. Bergler-Czop B, Lis-Swiety A, Brzezińska-Wcisło L. Scleroderma linearis: hemia-
trophia faciei progressive (Parry–Romberg syndrome) without any changes in 
CNS and linear scleroderma “en coup de sabre” with CNS tumor. BMC Neurol. 
2009;9:39.
14. Sommer A, Gambichler T, Bachrach-Buhles M, von Rothenburg T, Altmeyer P, 
Kreuter A. Clinical and serological characteristics of progressive facial hemiat-
rophy: a case of 12 patients. J Am Acad Dermatol. 2006;54:227-33.
15. Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with 
chronic Lyme disease. Immunol Lett. 2001;76:43-8.
16. Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: A rigorous re-
view of diagnostic criteria and treatment. J Autoimmun. 2015;57C:82-115.
